Glucose
- Generic Name
- Glucose
- Brand Names
- Bss Ophthalmic Solution, Citrasate, Clinimix 2.75/5, Clinimix E 2.75/5, Dextroject, Dianeal, H.E.L.P.bicel, Hemosate Ultra, Lactate 1-2-3, Leukotrap, Naturalyte, Nauzene, Normosol-R, Nxstage Pureflow, Olimel, Periolimel, Physioneal 40, Sag-M, Sclerodex, Selectbag One
- Drug Type
- Small Molecule
- Unique Ingredient Identifier
- IY9XDZ35W2
- Background
Glucose is a simple sugar (monosaccharide) generated during phosynthesis involving water, carbon and sunlight in plants. It is produced in humans via hepatic gluconeogenesis and breakdown of polymeric glucose forms (glycogenolysis). It circulates in human circulation as blood glucose and acts as an essential energy source for many organisms through aerobic or anaerobic respiration and fermentation. It is primarily stored as starch in plants and glycogen in animals to be used in various metabolic processes in the cellular level. Its aldohexose stereoisomer, dextrose or D-glucose, is the most commonly occurring isomer of glucose in nature. L-glucose is a synthesized enantiomer that is used as a low-calorie sweetener and laxative. The unspecified form of glucose is commonly supplied as an injection for nutritional supplementation or metabolic disorders where glucose levels are improperly regulated. Glucose is listed on the World Health Organization's List of Essential Medicines.
- Indication
Glucose pharmaceutical formulations (oral tablets, injections) are indicated for caloric supply and carbohydrate supplementation in case of nutrient deprivation. It is also used in metabolic disorders such as hypoglycemia.
- Associated Conditions
- Arrhythmia, Caloric Deficit, Edema of the cerebrum, Hypoglycemia, Metabolic Alkalosis
- Associated Therapies
- Blood Specimen Collection, Electrolyte replacement, Nutritional supplementation, Parenteral Nutrition, Parenteral rehydration therapy, Plasmapheresis, Positive cardiac inotropic effect, Total parenteral nutrition therapy, Urine alkalinization therapy, Fluid and electrolyte maintenance therapy
Local Injection of Steroid VS.Glucose 5% in Carpal Tunnel Syndrome
- First Posted Date
- 2022-08-11
- Last Posted Date
- 2022-08-11
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 52
- Registration Number
- NCT05496764
- Locations
- 🇪🇬
Assiut University Hospital, Assiut, Egypt
The Primary Objective of This Study Was to Investigate the Effect of Insulin on Myocardial Perfusion and Cardiac Function in Patients Undergoing Cardiac Surgery for CPB Using Transesophageal Echocardiography (TEE) to Detect CSBF
- Conditions
- Insulin
- Interventions
- Drug: Glucose insulin potassium
- First Posted Date
- 2022-07-19
- Last Posted Date
- 2024-01-19
- Lead Sponsor
- Yangzhou University
- Target Recruit Count
- 74
- Registration Number
- NCT05464966
- Locations
- 🇨🇳
the Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, Jiangsu, China
ENSO 16 - Study in Healthy Subjects
- First Posted Date
- 2022-07-14
- Last Posted Date
- 2023-02-21
- Lead Sponsor
- Alpha Republic GmbH
- Target Recruit Count
- 15
- Registration Number
- NCT05457400
- Locations
- 🇦🇹
Universitätsklinik für Klinische Pharmakologie,, Vienna, Austria
The Therapeutic Effects of Dextrose Injection for Myofascial Pain Syndrome
- Conditions
- Myofascial Trigger Point Pain
- Interventions
- Other: normal salineDrug: Dextrose 5% in waterDrug: Dextrose 15% in water
- First Posted Date
- 2022-06-23
- Last Posted Date
- 2025-01-01
- Lead Sponsor
- National Cheng-Kung University Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT05429827
- Locations
- 🇨🇳
Department of physical Medicine and Rehabilitation, National Cheng Kung University Hospital, Tainan, Taiwan
Impact of DApagliflozin on Cardiac Function Following Anterior Myocardial Infarction in Non-Diabetic Patients
- First Posted Date
- 2022-06-21
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Omar Younis
- Target Recruit Count
- 100
- Registration Number
- NCT05424315
- Locations
- 🇪🇬
Cardiology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
🇪🇬National Heart Institute, Cairo, Egypt
Functional and Electromyographical Changes After PRP or Dextrose Injection in Chronic Lateral Epicondylitis
- Conditions
- Tennis Elbow
- Interventions
- Drug: Dextrose 50%Drug: Platelet Rich Plasma
- First Posted Date
- 2022-04-14
- Last Posted Date
- 2022-04-14
- Lead Sponsor
- Chen Yueh
- Target Recruit Count
- 90
- Registration Number
- NCT05326763
- Locations
- 🇨🇳
Chen Yueh, Tainan, Taiwan
Effect of Intrathecal Neostigmine on Post-dural Puncture Headache.
- Conditions
- Post-Dural Puncture Headache
- Interventions
- Drug: Dextrose 5%/Nacl 0.9% Inj
- First Posted Date
- 2022-03-21
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- Alexandria University
- Target Recruit Count
- 722
- Registration Number
- NCT05289323
- Locations
- 🇪🇬
Alexandria University, Alexandria, Egypt
The Ultrasound-Guided Dextrose Prolotherapy in Ehlers-Danlos Syndrome Patients
- Conditions
- Ehlers-Danlos SyndromeLow Back PainSacroiliac Instability
- Interventions
- Drug: Dextrose 50% Intravenous Solution
- First Posted Date
- 2022-03-15
- Last Posted Date
- 2024-11-04
- Lead Sponsor
- Tulane University
- Target Recruit Count
- 40
- Registration Number
- NCT05279937
- Locations
- 🇺🇸
Tulane Hospital and Clinics, New Orleans, Louisiana, United States
Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid Infusion
- Conditions
- Type 2 DiabetesObesityHealthy
- Interventions
- Drug: Clinisol 15%
- First Posted Date
- 2022-03-03
- Last Posted Date
- 2024-05-29
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 60
- Registration Number
- NCT05264727
- Locations
- 🇺🇸
Mayo Clinic Rochester, Rochester, Minnesota, United States
Gastric Emptying Times of Normal and Obese Children After Preoperative Clear Fluid Drinking: An Ultrasound Study
- Conditions
- Gastric Emptying Time
- Interventions
- Drug: 5% Dextrose
- First Posted Date
- 2022-02-17
- Last Posted Date
- 2022-11-25
- Lead Sponsor
- Karaman Training and Research Hospital
- Target Recruit Count
- 70
- Registration Number
- NCT05244902
- Locations
- 🇹🇷
Karaman Taining and Research Hospital, Karaman, Turkey
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.